MCK McKesson Corporation

1062.16USD-2.05%Mkt Cap: 122.63B USDP/E: 27.40

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap122.63B USD
Enterprise Value132.82B USD
Revenue (TTM)418.79B USD
Gross Profit14.55B USD
Net Income (TTM)4.76B USD
Revenue/Share3487.01 USD
Last Price1062.16 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees41.6K
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)27.40
P/E (Forward)20.25
PEG1.87
EV/EBITDA18.19
EV/Revenue0.32
P/S0.29
P/B-30.89
EPS (TTM)38.77 USD
EPS (Forward)52.26 USD
52W Range
723.6885% of range1121.50
52W High1121.50 USD
52W Low723.68 USD
Profitability
Gross Margin3.61%
Oper. Margin1.59%
EBITDA Margin1.74%
Profit Margin1.18%
ROE-219.24%
ROA5.78%
ROIC139.48%
ROCE42.17%
Growth
Revenue Growth7.60%
Earnings Growth17.00%
Cash Flow & Leverage
Operating CF6.16B USD
CapEx (TTM)745.00M USD
FCF Margin1.77%
FCF Yield6.04%
Net Debt4.67B USD
Net Debt/EBITDA0.64
Net Debt/FCF0.63
Balance Sheet
Debt/Equity-3.97
Current Ratio0.90
Quick Ratio0.50
Book Value/Sh-34.38 USD
Cash/Share56.54 USD
Dividends
Fwd Div Rate3.76 USD
Trail. Div Rate3.40 USD
Div. Yield0.35%
5Y Avg Yield0.46%
Payout Ratio8.77%
Ex-Div DateDec 1, 2026
Pay DateJan 4, 2027
Splits
Last Split2:1
Split DateJan 5, 1998
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1161.07 USD
Upside (mean)+9.3%
Target Range965.00 USD – 1260.00 USD
965.00+9.3% to mean1260.00
# Analysts14
Ownership
Shares Out.115.46M
Float115.26M
Insiders0.09%
Institutions91.25%
Short Interest
Short Ratio2.8d
Short % Float1.73%
Short % Out.1.72%
Shares Short1.99M
Short (prev mo.)2.29M
Technical
SMA 50959.03 (+10.8%)
SMA 200875.63 (+21.3%)
Beta0.28
S&P 52W Chg12.08%
Avg Vol (30d)678.55K
Avg Vol (10d)749.56K
Technical Indicators
RSI (14)58.6
MACD33.7784
MACD Signal35.2599
MACD Hist.-1.4815
BB Upper1139.56 USD
BB Middle1042.15 USD
BB Lower944.74 USD
BB Width18.69%
ATR (14)25.73 USD
Vol Ratio (20d)0.89x

About McKesson (NYSE: MCK)

›

McKesson (NYSE: MCK) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 41,600 employees.

The shares were at 1062.16 USD on 19 November 2026, up 26.4% over 52 weeks. Its 52-week range is 723.68 USD to 1121.50 USD: the price is 5.3% below the high and 46.8% above the low.

At a market capitalisation of 122.63B USD, it trades at 27.4 times trailing earnings and 20.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 35% for MCK. It pays a dividend yielding 0.35% (it pays out 9% of its earnings), against a median of 2.55% among the dividend payers in that peer group.

McKesson reports return on equity of -219.2%, an operating margin of 1.6% and revenue up 7.6% year over year.

Its debt exceeds its cash by 4.67B USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 1161.07 USD is 9.3% above the current price. The next earnings report is expected on 3 February 2027.